BioMérieux's BioFire Diagnostics subsidary and Cepheid sponsored presentations at the American Association for Molecular Pathology annual meeting in which clinical users shared preliminary data on highly anticipated products from the companies.
NEW YORK (GenomeWeb) — BioMérieux said this week that its first quarter revenues increased 3 percent year over year but 8 percent when including sales from recent acquisition BioFire Diagnostics and at constant exchange rates.
Evogen, a Lenexa, Kansas-based developer of molecular detection and diagnostic technologies, said this week that it has non-exclusively licensed its PCR probe technology to Focus Diagnostics, a Quest Diagnostics subsidiary.
Researchers from Johns Hopkins University have reported that their high-resolution melting assay and a PCR/mass spectrometry approach using Abbot's Plex-ID platform performed similarly in identifying pathogens from a cohort of positive blood culture samples.
Researchers from several institutions have developed a high-resolution melting assay that can provide measurements of HIV diversity that are highly concordant with equivalent sequencing-based measurements at a fraction of the cost.